CA2376394A1 - Retro-inverso peptides derived from interleukin-3 - Google Patents

Retro-inverso peptides derived from interleukin-3 Download PDF

Info

Publication number
CA2376394A1
CA2376394A1 CA002376394A CA2376394A CA2376394A1 CA 2376394 A1 CA2376394 A1 CA 2376394A1 CA 002376394 A CA002376394 A CA 002376394A CA 2376394 A CA2376394 A CA 2376394A CA 2376394 A1 CA2376394 A1 CA 2376394A1
Authority
CA
Canada
Prior art keywords
peptide
sequence shown
seq
amino acid
retro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002376394A
Other languages
English (en)
French (fr)
Inventor
David E. Wright
D. Elliot Parks
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Myelos Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2376394A1 publication Critical patent/CA2376394A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002376394A 1999-06-16 2000-06-16 Retro-inverso peptides derived from interleukin-3 Abandoned CA2376394A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13968899P 1999-06-16 1999-06-16
US60/139,688 1999-06-16
PCT/US2000/016759 WO2000077028A1 (en) 1999-06-16 2000-06-16 Retro-inverso peptides derived from interleukin-3

Publications (1)

Publication Number Publication Date
CA2376394A1 true CA2376394A1 (en) 2000-12-21

Family

ID=22487853

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002376394A Abandoned CA2376394A1 (en) 1999-06-16 2000-06-16 Retro-inverso peptides derived from interleukin-3

Country Status (6)

Country Link
EP (1) EP1185552A1 (ja)
JP (2) JP2003502340A (ja)
AU (1) AU5496500A (ja)
CA (1) CA2376394A1 (ja)
IL (2) IL147093A0 (ja)
WO (1) WO2000077028A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
AU2003250697B2 (en) * 2002-07-30 2008-05-01 Stem Cell Therapeutics Inc. Oligodendrocyte production from multipotent neural stem cells
WO2004035086A2 (en) * 2002-10-16 2004-04-29 Hunter Samuel F Method for treatment of demyelinating central nervous system disease using gm-csf
US7695723B2 (en) * 2002-12-31 2010-04-13 Sygnis Bioscience Gmbh & Co. Kg Methods of treating neurological conditions with hematopoietic growth factors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700909A (en) * 1993-07-30 1997-12-23 The Regents Of The University Of California Prosaposin and cytokine-derived peptides
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
EP0979238A4 (en) * 1997-03-05 2000-08-23 Univ California METHOD FOR HEALING NEUROPATHIC PAIN
US6458357B1 (en) * 1997-09-09 2002-10-01 Myelos Corporation Retro-inverso neurotrophic and analgesic peptides

Also Published As

Publication number Publication date
IL147093A (en) 2011-04-28
AU5496500A (en) 2001-01-02
IL147093A0 (en) 2002-08-14
JP2011137019A (ja) 2011-07-14
WO2000077028A1 (en) 2000-12-21
JP2003502340A (ja) 2003-01-21
EP1185552A1 (en) 2002-03-13

Similar Documents

Publication Publication Date Title
CA2168029C (en) Prosaposin and cytokine-derived peptides as therapeutic agents
AU751034B2 (en) Cyclic prosaposin-derived peptides and uses thereof
US20110190213A1 (en) Retro-inverso peptides derived from interleukin-3
JP2011144184A (ja) 白血病阻害因子に由来するレトロ−インベルソなペプチド
JP2011137019A (ja) インターロイキン−３から誘導されるレトロ−インベルソペプチド
AU751161B2 (en) Retro-inverso neurotrophic and analgesic peptides
US8063016B2 (en) Retro-inverso peptides derived from interleukin-6
US7754690B2 (en) Method of using retro inverso peptides derived from leukemia inhibitory factor
JP4786843B2 (ja) インターロイキン−６から誘導されるレトロ−インベルソペプチド
AU2010200055C1 (en) Prosaposin and cytokine-derived peptides as therapeutic agents
CA2367766A1 (en) Retro-inverso prosaposin-derived peptides and use thereof
MXPA01001966A (en) Cyclic prosaposin-derived peptides and uses thereof

Legal Events

Date Code Title Description
FZDE Discontinued